Brad H. Nelson
Victoria, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Rethinking ovarian cancer III: the past decade and future directions.
Journal: Nature reviews. Cancer
Published: February 23, 2026
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Research square
Published: November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).
Journal: Cancer treatment and research communications
Published: September 30, 2025
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: September 22, 2025
Evaluation of Genomic Proximity Mapping for Detecting Genomic and Chromosomal Structural Variants in Constitutional Disorders.
Journal: The Journal of molecular diagnostics : JMD
Published: May 20, 2025
Evaluation of Genomic Proximity Mapping (GPM) for Detecting Genomic and Chromosomal Structural Variants in Constitutional Disorders.
Journal: medRxiv : the preprint server for health sciences
Published: May 02, 2025
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.
Journal: Cancer immunology research
Published: April 04, 2025
Polysialic acid is upregulated on activated immune cells and negatively regulates anticancer immune activity.
Journal: Frontiers in oncology
Published: October 31, 2024
Last Updated: 09/26/2026